NASDAQ
56.42USD
-4.18 (-6.90%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.7B
P/E
—
EPS
—
Beta
1.97
52W range
32.21-170.87
Day range
54.96–61.70
Open
60.50
Prev close
60.60
Volume
1.1M
Avg volume
1.3M
Dividend
0.00
IPO
2020-11-04
https://www.prnewswire.com/news-releases/wgs-investors-have-opportunity-to-lead-genedx-holdings-corp-securities-fraud-lawsuit-with-the-schall-law-firm-302799940.html · 6/15/2026-1.00
https://www.newsfilecorp.com/release/300920/RBLX-SHAREHOLDER-NOTICE-Faruqi-Faruqi-LLP-Notifies-Roblox-RBLX-Investors-of-Securities-Class-Action-Lawsuit-Deadline-on-August-7-2026 · 6/11/2026-0.50
https://www.globenewswire.com/news-release/2026/06/08/3308399/32716/en/GeneDx-Holdings-WGS-Faces-Securities-Class-Action-After-49-Drop-94-Write-off-Related-to-Fabric-Genomics-Acquisition-Hagens-Berman.html · 6/8/2026-1.00
https://www.newsfilecorp.com/release/300199/WGS-SHAREHOLDER-NOTICE-Faruqi-Faruqi-LLP-Reminds-GeneDx-WGS-Investors-of-Securities-Class-Action-Deadline-on-August-3-2026 · 6/6/2026
https://www.prnewswire.com/news-releases/genedx-holdings-wgs-faces-securities-class-action-after-49-drop-94-write-off-related-to-fabric-genomics-acquisition--hagens-berman-302792285.html · 6/5/2026-1.00
https://www.globenewswire.com/news-release/2026/05/27/3302462/32716/en/GeneDx-Holdings-WGS-49-Drop-Triggers-Investor-Scrutiny-Over-Disconnect-From-Prior-Growth-Narrative-Hagens-Berman.html · 5/27/2026-1.00
https://www.globenewswire.com/news-release/2026/05/21/3299833/32719/en/CHX-Class-Action-Notice-Robbins-LLP-Reminds-Investors-of-the-Lead-Plaintiff-Deadline-in-the-ChampionX-Corporation-Class-Action-Lawsuit.html · 5/21/2026-0.60
https://www.newsfilecorp.com/release/297775/Fraud-Investigation-Opened-Levi-Korsinsky-Investigates-GeneDx-Holdings-Corp.-WGS-on-Behalf-of-Shareholders · 5/18/2026-1.00
https://www.newsfilecorp.com/release/296864/Investigation-Alert-Option-Care-Health-Inc.-OPCH-Under-Scrutiny-Contact-Levi-Korsinsky-for-Details · 5/11/2026-0.80
https://www.newsfilecorp.com/release/296866/ATTENTION-RBLX-Investors-Securities-Fraud-Investigation-Underway-Contact-Levi-Korsinsky · 5/11/2026-0.80
https://www.globenewswire.com/news-release/2026/05/09/3291437/0/en/GENEDX-INVESTIGATION-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-GeneDx-Holdings-Corp-on-Behalf-of-GeneDx-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html · 5/9/2026-1.00
https://www.globenewswire.com/news-release/2026/05/07/3290473/0/en/INVESTOR-ALERT-Investigation-of-Option-Care-Health-Inc-OPCH-announced-by-Holzer-Holzer-LLC.html · 5/7/2026-0.50
GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
